FACT II Acquisition
FACT · NASDAQ
About FACT
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Nov 26, 2024
- Sector
- N/A
- Industry
- N/A
FACT key statistics
- Market cap
- 261.70M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 101.55K
- Volume
- 15
- Open price
- $10.76
- High today
- $10.76
- Low today
- $10.76
- 52 Week high
- $10.78
- 52 Week low
- $10.32
FACT II Acquisition (FACT) at a glance
As of Oct 23, 2026, FACT II Acquisition (FACT) shares are priced at $10.76, giving the company a market cap of 261.70M and a price-to-earnings ratio of 0.00.
Volume so far is 15 shares, below the average of 101.55K shares a day.
Over the past year FACT II Acquisition has ranged from $10.32 to $10.78, and now sits 97% of the way up that range.
FACT news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Precision Aerospace & Defense Group Reschedules Investor Day to March 12, 2026
- Press releaseBusiness Wire
Precision Aerospace & Defense Group to Host Investor Day on February 25, 2026
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.